Volume 9, Issue 1

• Predictors of Exercise in Individuals with Schizophrenia: A Test of the Transtheoretical Model of Behavior Change
  Author(s): Bridget Bassilios, Fiona Judd, Philippa Pattison, Angela Nicholas, Kristen Moeller-Saxone
  • Abstract
  • PDF
• An Open-Label Pilot Trial of Alpha-Lipoic Acid for Weight Loss in Patients with Schizophrenia without Diabetes
  Author(s): Joseph C. Ratliff, Laura B. Palmese, Erin L. Reutenauer, Cenk Tek
  • Abstract
  • PDF
• Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use: A Case Report
  Author(s): Dante Durand, Leticia L. Delgado, Dhizarah Matus de la Parra-Pellot, Diana Nichols-Vinueza
  • Abstract
  • PDF
• Maintenance Electroconvulsive Therapy for a Neuroleptic-Intolerant Patient with Disorganized Schizophrenia
  Author(s): Eyal Dahan, Evgenia Or, Avi Bleich, Yuval Melamed
  • Abstract
  • PDF
• Switching to Iloperidone: An Omnibus of Clinically Relevant Observations from a 12-Week, Open-Label, Randomized Clinical Trial in 500 Persons with Schizophrenia
  Author(s): Leslie Citrome, Peter J. Weiden, Gus Alva, Ira D. Glick, Richard Jackson, Greg Mattingly, Farid Kianifard, Xiangyi Meng, Adam Winseck
  • Abstract
  • PDF
• Drug development update
  Author(s): Peter F. Buckley
  • PDF